Summary
Introduction
The ideal composition of artificial nutrition for the newborn infant is not yet clearly defined. Manufacturing of infant formulae is mainly based on human milk composition, in which approximately 50% of the energy is provided by fat and 40% by carbohydrate. In total parenteral nutrition for neonates, the majority of the energy is provided by glucose. It is not known how much of this intravenously Using indirect calorimetry, we could not demonstrate such a limit in neonates on fat-free parenteral nutrition [5] . This might be due to conversion of glucose carbon into fat, which was then oxidized, with over-estimation of glucose oxidation as a result [6, 71 . We therefore combined indirect calorimetry with an independent method of estimating glucose oxidation rates, i.e. measurement of 13C0, exhalation during infusion of [U-13C]glucose. This paper was presented in part at the Meeting of the Society for Pediatric Research, in May 1984, San Francisco, CA, U.S.A. Table I) Sixteen appropriate-for-gestational age (AGA), nine full-term and seven premature, newborn infants entered the study. AGA was defined as birthweight between the 3rd and 97th percentiles for gestation, according to the criteria of Usher & McLean [ 81. Gestational age, determined by history and Dubowitz score [9] , ranged between 29 and 40 weeks (mean * SE: 36.3 * 0.9 weeks), birth weight between 1410 and 3900 g (2429 k 164 g) and study weight between 1450 and 3690 g (2467 * 155 8).
Methods

Subjects (
The postnatal age ranged between 4 and 32 days (14.1 If: 2.5 days). All infants were referred to the Neonatal Intensive Care Unit of The Hospital for Sick Children, Toronto, Canada. All were clinically stable at the time of the study, with normal renal function and normal arterial blood gases with no extra oxygen requirements. Nine of the babies had kg-I); protein: 3.12f 0.25 g day-' kg-' (range 0.0-4.2 g day-' kg-'). Fifteen infants received an intravenous mixture of 10% glucose and 2% amino acids; one patient received 10% glucose only.
Study procedure
The study protocol was approved by the Human Subject Review Committee of The Hospital for Sick Children, Toronto, Canada, and, for each baby, written, informed consent was obtained from one of the parents. The calorimetry and the primed constant infusion study were performed simultaneously over a period of 5 and 4 h respectively.
indirect calorimetry
The metabolic rate was measured by open circuit indirect calorimetrty. Continuous measurements t Amino acid content of Vamin [27] .
were performed during 5 h, as previously described [lo, 111. Each infant was studied in an incubator kept in the thermoneutral temperature range [ 121. The head was positioned in a transparent Perspex headbox, and the incubator air was drawn through the hood at a rate of 1 litre min-' kg-', measured by pneumotachometer (Fleisch ah 7317 no. 00, Dynasciences, Blue Bell, PA, U S A ) . The air was passed through a dual-channel paramagnetic oxygen analyser (Taylor Servomex OAl84, Crowborough, U.K.) and an infrared carbon dioxide analyser (Beckman, LB2, Palo Alto, CA, U.S.A.). The air in the incubator was analysed simultaneously.
Computerized on-line recording (9845A Hewlett-Packard, Mississauga, Canada) permitted calculations of the total oxygen consumption (Vo,), total carbon dioxide production ( Vco,) and respiratory quotient (RQ). During the study, urine was collected by using an adhesive rubber collector [ll] and urinary nitrogen excretion was determined by the micro-Kjeldahl method [13] in order to calculate protein oxidation and to derive non-protein RQ and non-protein oxygen consumption. Urinary glucose spill was checked to be negative by dipstick tests (Hemo-Combistix, Ames). Metabolic rate and partition of the non-protein macronutrients were calculated from non-protein RQ and non-protein Vo2, from the Tables of Lusk [ 141.
Isotope studies
Before infusion of the label, three separate baseline breath samples were collected during 10 min each for determination of the natural background of I3C. The bicarbonate pool was primed with 6.9 pmolkg of NaHI3CO, (6.9 mmolA solution) (Merck, Sharp, Dohme, Dorval, Quebec, Canada) as previously described [15] . At the same time, a [U-13C]glucose (3.2 mmolA solution) priming dose of 4.8 pmolkg was given, followed by a constant infusion of 2.7 pmol rnin-' kg-I, with a SAGE pump (model 341A, SAGE Instruments, Orion Research Inc., Cambridge, MA, U.S.A.). The 13C-isotope enrichment of [U-'3C]glucose was 98.1% (Merck, Sharp, Dohme). It was diluted in sterile water and tested for sterility and pyrogens.
The actual glucose concentration of the tracer infusate and the delivery rate of the pump during 6 h were measured to determine the actual quantity of [U-13C]glucose infused. The tracer was introduced into the main intravenous line with a needle (Minicath, 23 gauge, Deseret, Parke-Davis Co. Inc., Utah, U.S.A.) via the diaphragm of a T-connector (no. 4612 Abbott Hospital Inc., Chicago, IL, U.S.A.). The volume between entry of the isotope in the intravenous line and the entry of the intravenous line in the patient was 0.1 ml.
Once the isotope infusion was started, 10 min collections of CO, were made every 30 min for a total of eight samples. The methods used in this study to collect and analyse CO, breath samples have been described recently [15] . Briefly, the respiratory CO, was collected by passing the exhaust of the Beckman LB2 CO, analyser through an all-glass spiral condenser (Quickfit Condenser Gram, J. Bibby Science Products Ltd, Staffordshire, U.K.) containing 10 ml of 1 molA NaOH. The samples were stored in Vacutainers (no. 6441, Becton Dickinson, Ontario, Canada) at -20°C until analysis. Trapping of COz was shown to be complete and, hence, isotopic fractionation was prevented. To demonstrate that no significant shift in natural abundance occurs over time, we measured the variability of natural I3CO, excretion in two healthy infants over 6 h. The atoms '/o excess was 0.0312329 k 0.0007922 (meanf SD).
Mass spectrometric analysis
Torr by combining phosphoric acid (85%) with the NaHCO, solution in a high vacuum Rittenberg tube, as described previously [15] . The tube was then frozen in liquid nitrogen, immersed in a methanol/solid CO, bath and coupled to a mass spectrometer inlet. CO, was analysed for I3C abundance in a dual inlet isotope ratio mass spectrometer (Vacuum Generators Micromass 602D, Winsford, Cheshire, U.K.). Multiple analyses 100
Vco, is carbon dioxide production [ml (STDP) min-' kg-'1; H is plateau height of I3CO, (atoms % excess) above baseline; C is correction factor for 13C02 retention in the bicarbonate pool, calculated from energy intake [15]; 0.981 is the factor for atomic enrichment of labelled glucose. ; o of the plateau. intake.
. "
The glucose oxidation rate was calculated from the non-labelled glucose infusion and the I3C recovery: glucose oxidation = glucose infusion x I3C recovery.
The fat oxidation rate was calculated (a) from the rate obtained by indirect calorimetry (IDC); (b) as the difference between non-protein metabolic rate and [13C]glucose oxidation, divided by 38.7 kJ (per g of fat).
Linear regression analysis and paired t-test were used where applicable.
Results
The metabolic rate averaged 205.9 f 7.1 kJ day-' kg-' and correlated significantly with increasing glucose intake ( r = 0.68; P < 0.005).
The production of I3CO, in breath rose rapidly in the first hour of infusion to become constant in most subjects by 90 min and in all subjects by 120 min. There was less than 5% variation of isotopic abundance at plateau ( Fig. 1 : isotopic plateau was defined as the absence of any significant change in abundance with time).
Glucose utilization measured with indirect calorimetry increased significantly with increasing glucose intake ( r = 0.90; P < 0.001; y = -3.46 + 0.9248x), as did the glucose oxidation calculated from I3CO, excretion ( r = 0.87; P < 0.001; y = -1.92 + 0 . 6 2 0 8~) (Fig. 2) . For each additional gram of glucose intake, the increment in glucose oxidation was only two-thirds of the increment of the glucose utilization. In each individual patient, glucose utilization was higher than the glucose oxidation, resulting in a mean difference of 3.57 rt 0.44 g day-' kg-I ( P < 0.001 by paired t-test) ( Table 3 ).
The contribution of substrate utilization to metabolic rate, calculated by data obtained from direct calorimetry and I3C methodology, is shown in Fig.  3 . Protein oxidation, as calculated from urinary nitrogen excretion, represented 13.8% of the metabolic rate. Indirect calorimetry indicated that 190 kJ day-' kg-I was derived from glucose utilization, with concomitant fat storage of 12.6 kJ day-' kg-' or 0.32 g day-' kg-'. The [I3C]glucose methodology showed that 133.9 kJ day-' kg-' was derived from glucose oxidation. The remainder of the nonprotein metabolic rate must have been derived from fat oxidation, 43.5 kJ day-' kg-' or 1.13 g day-I kg-I ( P < 0.001 by paired t-test).
Discussion
The technique of indirect calorimetry has been used for many years to provide information on the type and rate of fuel oxidation in adults [l-3,7] and in newborn infants [5, 11, 171 . The rates of glucose and fat utilization, calculated from gaseous exchange and urinary nitrogen excretion, will not necessarily be equal to their oxidation rates. With use of labelled fat, studies in adults and in dogs have shown that fat oxidation continues even at RQ higher than 1 [18, 191, values -l kg-I) (g day-' kg-I) (g day-I kg-I) (g day-' kg-I) (g day-I kg-') calorimetry indicates that only glucose is being oxidized. Indirect calorimetry measures the disappearance rate of glucose, it being impossible to distinguish between glucose which is being oxidized directly and glucose which is converted into fat with simultaneous fat oxidation at an overall RQ of less than 1 [6, 71. The glucose disappearance rate measured at an overall RQ over 1 includes also glucose which is converted and stored as fat [7] . Indirect calorimetry, therefore, will overestimate the glucose oxidation and, at the same time, underestimate the fat oxidation when glucose is converted into fat and fat is oxidized. Some assumptions have to be made in order to validate the data obtained from oxidation of [U-'3C]glucose. Both exogenous and endogenous glucose can enter the glucose pool and leave it to be oxidized or stored as glycogen, fat or other carbon containing substances. The endogenous glucose production is largely suppressed, particularly in full-term neonates when a glucose infusion of 1.5 times the basal glucose production is given [l-3, 20-221. Moreover, during the infusion of glucose, lactate and pyruvate, substrates for gluconeogenesis are derived from the infusate [23] . As the maximum (fasting) endogenous glucose production of newborn infants is 5-6 mg day-' kg-' [20, 21, 241 , the present study was performed with a glucose infusion of at least 7 mg day-' kg-' and at higher energy intakes than previously reported [20, 231. Although endogenous glucose production is not completely suppressed in preterm infants on low energy intakes during the first 2 days of life [21] , this is probably a temporary unresponsiveness disappearing after 1 week of life. All but one of the preterm infants in our study were older than 1 week and received both a high energy intake and a glucose intake of more than 9.5 mg day-' kg-'. Under these circumstances, we think it is reasonable to assume that the endogenous glucose production is suppressed and hence the glucose infusion rate to be equal to the total amount of glucose entering the glucose pool. A second assumption is that the size of the glucose pool is constant during the study aild that the labelled glucose is evenly distributed in the body [25] . The fact that we obtained a plateau of I3C enrichment in breath is consistent with this assumption. Finally, as in all tracer studies, it has to be assumed that the labelled substrate is metabolized equally with the unlabelled substrate. Although isotopes might be selectively fractionated in certain enzymatic processes, the errors involved in the determination of substrate kinetics in vivo are of such a magnitude that small isotopic effects are not an important factor 125 I.
Both the glucose utilization measured by indirect calorimetry and the glucose oxidation measured by the 13C technique increased significantly with glucose intake, but the slope of the glucose oxidation was only two-thirds of the slope of the glucose utilization (Fig. 2) . The I3C method measures the glucose carbon atoms which are being oxidized either to provide energy for maintenance and activity or to provide energy for the conversion of glucose into fat, which is an energy consuming process. Indirect calorimetry measures the disappearance rate of glucose, including the glucose converted into fat. The difference between the two slopes of Fig. 2 is equal to the amount of glucose stored as fat, which increases with increasing glucose intake. Lipogenesis from glucose is energy wasting and produces more CO, than it consumes 02. Metabolic rate, CO, production and 0, consumption therefore will increase with increasing glucose intake, as shown previously [5] .
Wolfe et al.
[l] compared glucose utilization calculated from indirect calorimetry with glucose oxidation measured with ['3C]glucose in fasting adults. Glucose utilization was significantly higher compared with the glucose oxidation. Similar results have recently been reported in fasting newborn infants 1261. Glucose oxidation rate measured by the ['3C]glucose methodology is probably underestimated in these fasting subjects owing to endogenous glucose entering the glucose pool.
No previous studies have compared substrate utilization measured by indirect calorimetry with oxidation rates measured with labelled substrates in newborn parenterally fed infants. Although indirect calorimetry gives an accurate estimate of substrate fluxes in the body, combination with the stable isotope tracer techniques allows the determination of the true substrate oxidation rates in infants. We suggest that the physiological stress imposed by high glucose loads, resulting in lipogenesis and increased energy expenditure, 0, consumption and CO, production could perhaps be eliminated by addition of lipids to the intravenous feeding of newborn infants.
